Danaher Corp (DHR)

231.45 -6.00 (-2.53%)
Close EUR Disclaimer

Danaher Corp Company Profile

Sector
Healthcare
Employees
63000
Equity Type
ORD
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians’ offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.
Contact Information
Address
Washington,20037-1701 United States
Phone
202 828 0850
Fax
202 828 0860
Top Executives
Name
Age
Since
Title
Mitchell P. Rales 66 1983 Co-Founder & Director
Rainer M. Blair 59 2014 President, CEO & Director
Alan G. Spoon 72 1999 Independent Director
Steven M. Rales 72 1983 Co-Founder & Chairman
Linda Hefner Filler 63 2005 Lead Independent Director
John T. Schwieters 83 2003 Independent Director
Raymond C. Stevens 60 2017 Independent Director
Teri L. List-Stoll 61 2011 Independent Director
Elias Adam Zerhouni 73 2009 Independent Director
Pardis C. Sabeti 48 2019 Director
Carl H. June 70 2022 Member of the Scientific Advisory Board
Jessica L. Mega 49 2019 Independent Director
James J. Collins 58 2021 Member of Scientific Advisory Board
A. Shane Sanders 61 2021 Independent Director
David R. Walt 71 2021 Member of Scientific Advisory Board
Angela M. Caliendo 0 2021 Member of Scientific Advisory Board
Thomas Christian Sudhof 69 2021 Member of Scientific Advisory Board
Feroz Dewan 48 2022 Independent Director
David L. Rimm 0 2021 Member of Scientific Advisory Board
Sangeeta N. Bhatia 55 2022 Member of Scientific Advisory Board
Robert M. Hershberg 62 0000 Member of Scientific Advisory Board
Phillip A. Sharp 79 2021 Member of Scientific Advisory Board
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles